カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のプロスタサイクリン薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Prostacyclin Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19576）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19576
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のプロスタサイクリン薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

プロスタサイクリン薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のプロスタサイクリン薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

プロスタサイクリン薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム

用途別セグメントは次のように区分されます。
・注射用、経口用、吸入用

世界のプロスタサイクリン薬物市場の主要な市場プレーヤーは以下のとおりです。
・United Therapeutics、Actelion (J & J)、GSK、Teva、Toray、Tide Pharma、Bayer AG

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、プロスタサイクリン薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロスタサイクリン薬物メーカーの企業概要、2019年～2022年までのプロスタサイクリン薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロスタサイクリン薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別プロスタサイクリン薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのプロスタサイクリン薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロスタサイクリン薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびプロスタサイクリン薬物の産業チェーンを掲載しています。
・第13、14、15章では、プロスタサイクリン薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- プロスタサイクリン薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム
- 用途別分析（2017年vs2021年vs2028年）：注射用、経口用、吸入用
- 世界のプロスタサイクリン薬物市場規模・予測
- 世界のプロスタサイクリン薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- United Therapeutics、Actelion (J & J)、GSK、Teva、Toray、Tide Pharma、Bayer AG
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム
・用途別分析2017年-2028年：注射用、経口用、吸入用
・プロスタサイクリン薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・プロスタサイクリン薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・プロスタサイクリン薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・プロスタサイクリン薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・プロスタサイクリン薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Prostacyclin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prostacyclin Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. For Injection accounting for % of the Prostacyclin Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Epoprostenol Sodium segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prostacyclin Drug include United Therapeutics, Actelion (J & J), GSK, Teva, and Toray, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prostacyclin Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Market segment by Application can be divided into
For Injection
For Oral
For Inhalation
The key market players for global Prostacyclin Drug market are listed below:
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostacyclin Drug, with price, sales, revenue and global market share of Prostacyclin Drug from 2019 to 2022.
Chapter 3, the Prostacyclin Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prostacyclin Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostacyclin Drug.
Chapter 13, 14, and 15, to describe Prostacyclin Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Prostacyclin Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostacyclin Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostacyclin Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Global Prostacyclin Drug Market Size & Forecast
1.4.1 Global Prostacyclin Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prostacyclin Drug Sales in Volume (2017-2028)
1.4.3 Global Prostacyclin Drug Price (2017-2028)
1.5 Global Prostacyclin Drug Production Capacity Analysis
1.5.1 Global Prostacyclin Drug Total Production Capacity (2017-2028)
1.5.2 Global Prostacyclin Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostacyclin Drug Market Drivers
1.6.2 Prostacyclin Drug Market Restraints
1.6.3 Prostacyclin Drug Trends Analysis
2 Manufacturers Profiles
2.1 United Therapeutics
2.1.1 United Therapeutics Details
2.1.2 United Therapeutics Major Business
2.1.3 United Therapeutics Prostacyclin Drug Product and Services
2.1.4 United Therapeutics Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Actelion (J & J)
2.2.1 Actelion (J & J) Details
2.2.2 Actelion (J & J) Major Business
2.2.3 Actelion (J & J) Prostacyclin Drug Product and Services
2.2.4 Actelion (J & J) Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Prostacyclin Drug Product and Services
2.3.4 GSK Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Prostacyclin Drug Product and Services
2.4.4 Teva Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Toray
2.5.1 Toray Details
2.5.2 Toray Major Business
2.5.3 Toray Prostacyclin Drug Product and Services
2.5.4 Toray Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tide Pharma
2.6.1 Tide Pharma Details
2.6.2 Tide Pharma Major Business
2.6.3 Tide Pharma Prostacyclin Drug Product and Services
2.6.4 Tide Pharma Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Prostacyclin Drug Product and Services
2.7.4 Bayer AG Prostacyclin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prostacyclin Drug Breakdown Data by Manufacturer
3.1 Global Prostacyclin Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prostacyclin Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prostacyclin Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Prostacyclin Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Prostacyclin Drug Manufacturer Market Share in 2021
3.5 Global Prostacyclin Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prostacyclin Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prostacyclin Drug Market Size by Region
4.1.1 Global Prostacyclin Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Prostacyclin Drug Revenue by Region (2017-2028)
4.2 North America Prostacyclin Drug Revenue (2017-2028)
4.3 Europe Prostacyclin Drug Revenue (2017-2028)
4.4 Asia-Pacific Prostacyclin Drug Revenue (2017-2028)
4.5 South America Prostacyclin Drug Revenue (2017-2028)
4.6 Middle East and Africa Prostacyclin Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prostacyclin Drug Sales in Volume by Type (2017-2028)
5.2 Global Prostacyclin Drug Revenue by Type (2017-2028)
5.3 Global Prostacyclin Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prostacyclin Drug Sales in Volume by Application (2017-2028)
6.2 Global Prostacyclin Drug Revenue by Application (2017-2028)
6.3 Global Prostacyclin Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prostacyclin Drug Sales by Type (2017-2028)
7.2 North America Prostacyclin Drug Sales by Application (2017-2028)
7.3 North America Prostacyclin Drug Market Size by Country
7.3.1 North America Prostacyclin Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Prostacyclin Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prostacyclin Drug Sales by Type (2017-2028)
8.2 Europe Prostacyclin Drug Sales by Application (2017-2028)
8.3 Europe Prostacyclin Drug Market Size by Country
8.3.1 Europe Prostacyclin Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Prostacyclin Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prostacyclin Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Prostacyclin Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Prostacyclin Drug Market Size by Region
9.3.1 Asia-Pacific Prostacyclin Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prostacyclin Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prostacyclin Drug Sales by Type (2017-2028)
10.2 South America Prostacyclin Drug Sales by Application (2017-2028)
10.3 South America Prostacyclin Drug Market Size by Country
10.3.1 South America Prostacyclin Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Prostacyclin Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prostacyclin Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Prostacyclin Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Prostacyclin Drug Market Size by Country
11.3.1 Middle East & Africa Prostacyclin Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prostacyclin Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prostacyclin Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prostacyclin Drug
12.3 Prostacyclin Drug Production Process
12.4 Prostacyclin Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prostacyclin Drug Typical Distributors
13.3 Prostacyclin Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Prostacyclin Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Prostacyclin Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. United Therapeutics Major Business
Table 5. United Therapeutics Prostacyclin Drug Product and Services
Table 6. United Therapeutics Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
Table 8. Actelion (J & J) Major Business
Table 9. Actelion (J & J) Prostacyclin Drug Product and Services
Table 10. Actelion (J & J) Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Prostacyclin Drug Product and Services
Table 14. GSK Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Teva Basic Information, Manufacturing Base and Competitors
Table 16. Teva Major Business
Table 17. Teva Prostacyclin Drug Product and Services
Table 18. Teva Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Toray Basic Information, Manufacturing Base and Competitors
Table 20. Toray Major Business
Table 21. Toray Prostacyclin Drug Product and Services
Table 22. Toray Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Tide Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Tide Pharma Major Business
Table 25. Tide Pharma Prostacyclin Drug Product and Services
Table 26. Tide Pharma Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 28. Bayer AG Major Business
Table 29. Bayer AG Prostacyclin Drug Product and Services
Table 30. Bayer AG Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Prostacyclin Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Prostacyclin Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Prostacyclin Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Prostacyclin Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Prostacyclin Drug Production Site of Key Manufacturer
Table 36. Prostacyclin Drug New Entrant and Capacity Expansion Plans
Table 37. Prostacyclin Drug Mergers & Acquisitions in the Past Five Years
Table 38. Global Prostacyclin Drug Sales by Region (2017-2022) & (K Units)
Table 39. Global Prostacyclin Drug Sales by Region (2023-2028) & (K Units)
Table 40. Global Prostacyclin Drug Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Prostacyclin Drug Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 43. Global Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 44. Global Prostacyclin Drug Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Prostacyclin Drug Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Prostacyclin Drug Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Prostacyclin Drug Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 49. Global Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 50. Global Prostacyclin Drug Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Prostacyclin Drug Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Prostacyclin Drug Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Prostacyclin Drug Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Prostacyclin Drug Sales by Country (2017-2022) & (K Units)
Table 55. North America Prostacyclin Drug Sales by Country (2023-2028) & (K Units)
Table 56. North America Prostacyclin Drug Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Prostacyclin Drug Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 59. North America Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 60. North America Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 61. North America Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 62. Europe Prostacyclin Drug Sales by Country (2017-2022) & (K Units)
Table 63. Europe Prostacyclin Drug Sales by Country (2023-2028) & (K Units)
Table 64. Europe Prostacyclin Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Prostacyclin Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 67. Europe Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 68. Europe Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 69. Europe Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Prostacyclin Drug Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Prostacyclin Drug Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Prostacyclin Drug Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Prostacyclin Drug Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 78. South America Prostacyclin Drug Sales by Country (2017-2022) & (K Units)
Table 79. South America Prostacyclin Drug Sales by Country (2023-2028) & (K Units)
Table 80. South America Prostacyclin Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Prostacyclin Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 83. South America Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 84. South America Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 85. South America Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Prostacyclin Drug Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Prostacyclin Drug Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Prostacyclin Drug Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Prostacyclin Drug Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Prostacyclin Drug Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Prostacyclin Drug Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Prostacyclin Drug Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Prostacyclin Drug Sales by Application (2023-2028) & (K Units)
Table 94. Prostacyclin Drug Raw Material
Table 95. Key Manufacturers of Prostacyclin Drug Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Prostacyclin Drug Typical Distributors
Table 99. Prostacyclin Drug Typical Customers
List of Figures
Figure 1. Prostacyclin Drug Picture
Figure 2. Global Prostacyclin Drug Revenue Market Share by Type in 2021
Figure 3. Epoprostenol Sodium
Figure 4. Treprostinil
Figure 5. Iloprost
Figure 6. Beraprost Sodium
Figure 7. Global Prostacyclin Drug Revenue Market Share by Application in 2021
Figure 8. For Injection
Figure 9. For Oral
Figure 10. For Inhalation
Figure 11. Global Prostacyclin Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Prostacyclin Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Prostacyclin Drug Sales (2017-2028) & (K Units)
Figure 14. Global Prostacyclin Drug Price (2017-2028) & (US$/Unit)
Figure 15. Global Prostacyclin Drug Production Capacity (2017-2028) & (K Units)
Figure 16. Global Prostacyclin Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Prostacyclin Drug Market Drivers
Figure 18. Prostacyclin Drug Market Restraints
Figure 19. Prostacyclin Drug Market Trends
Figure 20. Global Prostacyclin Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Prostacyclin Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Prostacyclin Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Prostacyclin Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Prostacyclin Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Prostacyclin Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Prostacyclin Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Prostacyclin Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Prostacyclin Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Prostacyclin Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Prostacyclin Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Prostacyclin Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Prostacyclin Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Prostacyclin Drug Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Prostacyclin Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Prostacyclin Drug Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Prostacyclin Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Prostacyclin Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Prostacyclin Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Prostacyclin Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Prostacyclin Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Prostacyclin Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Prostacyclin Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Prostacyclin Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Prostacyclin Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Prostacyclin Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Prostacyclin Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Prostacyclin Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Prostacyclin Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Prostacyclin Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Prostacyclin Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Prostacyclin Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Prostacyclin Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Prostacyclin Drug in 2021
Figure 79. Manufacturing Process Analysis of Prostacyclin Drug
Figure 80. Prostacyclin Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19576 )"世界のプロスタサイクリン薬物市場2022年：市場規模予測（～2028年）" (英文：Global Prostacyclin Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。